Edison Nation, Inc. Reports Financial Results for the Second Quarter Ended June 30, 2020

Rhea-AI Summary

Edison Nation, Inc. (NASDAQ:EDNT) reported record quarterly revenue of $6.8 million for Q2 2020, up 15.28% from $5.9 million in Q2 2019. EN Medical, the company's medical division, generated $3.0 million in revenue, with deferred revenue of $0.9 million and pending purchase orders of $9.9 million. Despite the positive revenue, the company incurred a net loss of $1.6 million for the quarter. Adjusted EBITDA was negative at ($0.006 million), a decline from positive earnings the previous year. The first half of 2020 showed total revenue at $10.5 million, a decrease compared to 2019.

Positive

• Record quarterly revenue of $6.8 million, a 15.28% increase from Q2 2019.
• EN Medical generated $3.0 million in revenue, with a deferred revenue of $0.9 million.
• Pending purchase orders for EN Medical total $9.9 million.

Negative

• Net loss of $1.6 million for Q2 2020, though improved from $1.7 million in Q2 2019.
• Adjusted EBITDA was negative at ($0.006 million), down from positive $0.009 million in Q2 2019.
• First six months revenue decreased by $1.16 million, totaling $10.5 million compared to $11.7 million in 2019.

Company Announces Record Quarterly Revenue

Bethlehem, P.A., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Edison Nation, Inc. (NASDAQ:EDNT), a multifaceted ecosystem that fosters innovation and drives IP, media and consumer products, today announced results for the second quarter ended June 30, 2020.

Company Highlights

• Company announces record quarterly revenue of $6.8 million.
• Relaunch of Edison Nation Medial division (“EN Medical), distributing personal protective equipment (“PPE”) and ancillary medical supplies to hospitals, government agencies, educational facilities and distributors.
• Formation of Global Clean Solutions (“Global”), producing proprietary sanitizer stands with subscription-based refills of our in-house sanitizer, Purple Mountain Clean. Global secured a three-year contract with an additional two-year option to supply a large municipality with its Purple Mountain Clean hand sanitizer.
• EN Medical/Global revenue for the second quarter was $3.0M. Additionally, EN Medical has deferred revenue of $0.9M, which is net revenue based on fees for facilitating the shipment of goods and not the actual dollar value of the goods that were shipped to customers.
• EN Medical purchase orders received in the second quarter that are pending shipment total $9.9M and the total open purchase orders for EN Medical as of today’s date are $44.4M.
• Edison Nation product sales for its core operations were $3.8M for the second quarter including increased sales on marketplaces such as Amazon.
• Beta version of ENovation ENgine, a SaaS platform to engage early stage businesses and entrepreneurs.
• Expansion of Pressix licensing agreement, and licensing of Table-to-Go from Edison Nation community.
• Return of Emmy-Award winning television show, Everyday Edisons, streaming on Crackle.

First Quarter 2020 Financial Summary

Revenue

• Second quarter 2020 revenue increased to $6.8 million as compared to $5.9 million revenue in the second quarter of 2019, an increase of 15.28%. The increase in revenue was primarily the result of an increase in business and new customers under the Company’s Edison Nation Medical operations.
• First six months revenue of $10.5 million was a decrease of $1.16 million as compared to revenue of $11.7 million for the first six months of 2019.

Net Loss

• Net loss in the second quarter of 2020 was $1.6 million, or ($0.18) per basic and diluted share, compared to a net loss of $1.7 million, or ($0.30) per basic and diluted share in the second quarter of 2019.
• Net loss for the first six months of 2020 was $.33 million, or ($0.04) per basic and diluted share, compared to a net loss of $3.1 million, or ($0.55) per basic and diluted share in the second quarter of 2019.

Adjusted EBITDA

• Adjusted EBITDA, a non-GAAP measure, totaled a negative $0.006 million in the second quarter of 2020, compared to a positive $0.009 million in the second quarter of 2019.
• Adjusted EBITDA, a non-GAAP measure, totaled negative $0.917 million in the first six months of 2020, compared to negative $0.193 million in the first six months of 2019.

See below, under the heading “Use of Non-GAAP Financial Information,” for a discussion of Adjusted EBITDA and a reconciliation of such measure to the most comparable measure calculated under U.S. generally accepted accounting principles (“GAAP”).

		Three Months Ended June 30,								Six Months Ended June 30,
		2020				2019				2020				2019
Net (loss)		$	(1,602,139	)		$	(1,775,065	)		$	(332,647	)		$	(3,153,462	)
Interest expense, net			841,529				401,170				1,571,111				525,864
Income tax expense			-				51,005				-				74,200
Depreciation and amortization			296,108				332,187				612,406				633,570
EBITDA			(458,877	)			(990,703	)			1,850,870				(1,919,828	)
Stock-based compensation			268,916				346,071				1,588,427				708,490
Restructuring and severance costs			189,009				134,597				431,145				170,982
Transaction and acquisition costs			-				-				82,736				223,538
Other non-recurring costs			-				519,191				40,860				623,365
Gain on divestiture			-				-				(4,911,760	)			-
Adjusted EBITDA (1)		$	(952	)		$	9,156			$	(917,722	)		$	(193,453	)

(1)

On June 8, 2020 the Company entered into a binding memorandum of understating (the “Agreement”) with Office Mart, Inc. (the “Customer”) and Zaaz Medical, Inc. (the “Sourcing Partner”) (collectively “the Parties”) to deliver certain goods to a third party (the “Transaction”). The Company was responsible for bringing the parties together and satisfied its performance obligation under the agreement. On August 10, 2020, the Company entered into an amendment to the Agreement (the “Amendment”) related to the Transaction whereas the Company and the Customer agreed to the settlement of the fees earned related to the Transaction of $907,500 as of June 30, 2020. The Transaction was recorded in accounts receivable and deferred revenues as of June 30, 2020 on the balance sheet with no impact to the condensed consolidated statement of operations. The Company has elected to defer the revenues until cash collection, but had the Company recognized the revenues adjusted EBITDA would have been $906,548 and $(10,222) for the three and six months ended June 30, 2020, respectively.

Management Commentary

Chris Ferguson, Chief Executive, commented, “During a challenging time in the world, our team has performed above and beyond expectations in both the core product business and the relaunch of Edison Nation Medical. The third quarter of 2020 will be the first full fiscal quarter for the new EN Medical, and we are excited for the continued validation and expansion of the Edison Nation business model.” About Edison Nation, Inc.

Edison Nation, Inc. is a multifaceted ecosystem which fosters innovation, driving IP, media and innovative consumer products. Edison Nation offers innovation sourcing, design, sales, fulfillment and shipping services. The Edison Nation Innovation Platform sources innovative ideas for internal launch or license to brand partners. Edison Nation hopes to leverage its television property “Everyday Edisons” to become the recognized leader in the innovator community.

For more information, please visit www.edisonnation.com.

Use of Non-GAAP Financial Information

EBITDA and Adjusted EBITDA is a financial measure that is not calculated in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes that because Adjusted EBITDA excludes (i) certain non-cash expenses (such as depreciation, amortization and stock-based compensation) and (ii) expenses that are not reflective of the Company’s core operating results over time (such as restructuring costs, litigation or dispute settlement charges or gains, and transaction-related costs), this measure provides investors with additional useful information to measure the Company’s financial performance, particularly with respect to changes in performance from period to period. Edison Nation management uses EBITDA and Adjusted EBITDA (a) as a measure of operating performance; (b) for planning and forecasting in future periods; and (c) in communications with the Company’s Board of Directors concerning Edison Nation’s financial performance. The Company’s presentation of EBITDA and Adjusted EBITDA are not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation and should not be used by investors as a substitute or alternative to net income or any measure of financial performance calculated and presented in accordance with U.S. GAAP. Instead, management believes EBITDA and Adjusted EBITDA should be used to supplement the Company's financial measures derived in accordance with U.S. GAAP to provide a more complete understanding of the trends affecting the business.

Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing the Company’s views as of any subsequent date. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including consumer, regulatory and other factors affecting demand for the Company’s products, any difficulty in marketing the Company’s products in global markets, competition in the market for consumer products and inability to raise capital to fund operations and service the Company’s debt. Additional information that could lead to material changes in the Company’s performance is contained in its filings with the SEC. The Company is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of new information, future events or otherwise.

Edison Nation, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS

		June 30, 2020				December 31, 2019
		(Unaudited)
Assets
Current assets:
Cash and cash equivalents		$	1,762,337			$	412,719
Accounts receivable, net			3,086,195				2,108,099
Inventory			1,190,998				1,369,225
Prepaid expenses and other current assets			1,884,542				917,433
Income tax receivable			147,889				147,889
Total current assets			8,071,961				4,955,365
Property and equipment, net			932,027				931,968
Right of use assets, net			578,280				732,100
Intangible assets, net			11,047,515				11,598,063
Goodwill			5,392,123				5,392,123
Total assets		$	26,021,906			$	23,609,619
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable		$	3,047,197			$	7,397,650
Accrued expenses and other current liabilities			1,704,484				1,594,669
Deferred revenues			1,061,989				159,591
Current portion of operating leases liabilities			279,427				272,215
Income tax payable			8,446				22,919
Line of credit, net of debt issuance costs of $0 and $15,573, respectively			2,151,108				456,995
Current portion of convertible notes payable, net of debt issuance costs of $535,235			900,765				-
Current portion of notes payable, net of debt issuance costs of $86,349 and $212,848, respectively			970,710				1,365,675
Current portion of notes payable – related parties			1,166,365				1,686,352
Due to related party			26,784				17,253
Total current liabilities			11,317,275				12,973,319
Operating leases liabilities –net of current portion			326,482				482,212
Convertible notes payable – related parties, net of current portion, net of debt discount of $316,667 and $366,666, respectively			1,111,495				1,061,495
Notes payable, net of current portion			825,004				42,492
Notes payable – related parties, net of current portion			1,501,148				1,595,669
Total liabilities			15,081,404				16,155,187
Commitments and Contingencies (Note 8)
Stockholders’ equity
Preferred stock, $0.001 par value, 30,000,000 shares authorized; 0 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively		$	-			$	-
Common stock, $0.001 par value, 250,000,000 shares authorized; 9,618,401 and 8,015,756 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively			9,618				8,016
Additional paid-in-capital			30,802,083				26,259,575
Accumulated deficit			(18,850,350	)			(18,495,461	)
Total stockholders’ equity attributable to Edison Nation, Inc.			11,961,351				7,772,130
Noncontrolling interests			(1,020,849	)			(317,698	)
Total stockholders’ equity			10,940,502				7,454,432
Total liabilities and stockholders’ equity		$	26,021,906			$	23,609,619

Edison Nation, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

		For the Three Months Ended June 30,								For the Six Months Ended June 30,
		2020				2019				2020				2019
Revenues, net		$	6,880,026			$	5,968,255			$	10,547,136			$	11,706,789
Cost of revenues			4,889,784				3,924,252				7,308,196				7,869,810
Gross profit			1,990,242				2,044,003				3,283,940				3,836,979
Operating expenses:
Selling, general and administrative			2,770,930				3,392,596				6,963,643				6,441,784
Operating loss			(780,688	)			(1,348,593	)			(3,724,703	)			(2,604,805	)
Other (expense) income:
Rental income			25,703				25,703				51,407				51,407
Interest expense			(847,154	)			(401,170	)			(1,571,111	)			(525,864	)
Gain on divestiture			-				-				4,911,760				-
Total other (expense) income			(821,451	)			(375,467	)			3,392,056				(474,457	)
Loss before income taxes			(1,602,139	)			(1,724,060	)			(332,647	)			(3,079,262	)
Income tax expense			-				51,005				-				74,200
Net loss		$	(1,602,139	)		$	(1,775,065	)		$	(332,647	)		$	(3,153,462	)
Net income (loss) attributable to noncontrolling interests			22,241				(39,648	)			22,241				17,245
Net loss attributable to Edison Nation, Inc.		$	(1,624,380	)		$	(1,735,417	)		$	(354,888	)		$	(3,170,707	)
Net loss per share:
Net loss per share – basic and diluted		$	(0.18	)		$	(0.30	)		$	(0.04	)		$	(0.55	)
Weighted average number of common shares outstanding – basic and diluted			8,920,554				5,702,693				8,551,012				5,682,150

Edison Nation, Inc. and Subsidiaries
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

		Six Months Ended June 30,
		2020				2019
Cash Flow from Operating Activities
Net loss attributable to Edison Nation, Inc.		$	(354,888	)		$	(3,170,707	)
Net income attributable to noncontrolling interests			22,241				17,245
Net loss			(332,647	)			(3,153,462	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			612,406				633,570
Amortization of financing costs			1,227,046				391,223
Stock-based compensation			1,588,427				708,490
Amortization of right of use asset			153,820				155,408
Gain on divestiture			(4,911,760	)			-
Changes in assets and liabilities:
Accounts receivable			(978,097	)			(1,215,155	)
Inventory			178,227				(336,544	)
Prepaid expenses and other current assets			(967,109	)			(561,331	)
Accounts payable			(344,847	)			1,191,252
Accrued expenses and other current liabilities			1,425,622				480,928
Operating lease liabilities			(148,518	)			(144,132	)
Due from related party			9,532				(65,600	)
Net cash used in operating activities			(2,487,898	)			(1,915,353	)
Cash Flows from Investing Activities
Purchases of property and equipment			(61,917	)			(106,770	)
Net cash used in investing activities			(61,917	)			(106,770	)
Cash Flows from Financing Activities
Borrowings under lines of credit, net			1,678,540				240,000
Borrowings under convertible notes payable			1,436,000				1,111,111
Borrowings under notes payable			1,767,352				1,110,000
Repayments under lines of credit			-				(31,542	)
Repayments under notes payable			(824,472	)			(566,710	)
Repayments under notes payable – related parties			(14,508	)			(40,997	)
Fees paid for financing costs			(143,479	)			(427,411	)
Net cash provided by financing activities			3,899,433				1,394,451
Net increase (decrease) in cash and cash equivalents			1,349,618				(627,672	)
Cash and cash equivalents – beginning of period			412,719				2,052,731
Cash and cash equivalents – end of period		$	1,762,337				1,425,059
Supplemental Disclosures of Cash Flow Information
Cash paid during the period for:
Interest		$	144,740			$	74,908
Income taxes		$	235,725			$	-
Noncash investing and financing activity:
Shares issued to note holders		$	-			$	173,300
Conversion under notes payable		$	424,000			$	-

Investor Relations:

Aimee Carroll, Edison Nation, Inc.
Phone: (484) 893-0060
Email: investors@edisonnation.com

FAQ

What are the Q2 2020 financial results of Edison Nation, Inc. (EDNT)?

Edison Nation, Inc. reported a record revenue of $6.8 million in Q2 2020, a 15.28% increase from Q2 2019, but incurred a net loss of $1.6 million.

How did EN Medical perform in the second quarter of 2020?

EN Medical generated $3.0 million in revenue for Q2 2020, with pending purchase orders totaling $9.9 million.

What is the Adjusted EBITDA for Edison Nation for Q2 2020?

The Adjusted EBITDA for Q2 2020 was negative $0.006 million, compared to positive $0.009 million in Q2 2019.

What was the revenue trend for Edison Nation in the first half of 2020?

Total revenue for the first six months of 2020 was $10.5 million, a decrease of $1.16 million compared to $11.7 million in the first half of 2019.